Market Tracker

09/23 5:16pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.01
Delayed Data
As of Sep 23
 -0.11 / -1.80%
Today’s Change
3.61
Today|||52-Week Range
8.37
-1.96%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close6.12
Today’s open6.12
Day’s range6.00 - 6.19
Volume853,321
Average volume (3 months)1,376,500
Market cap$420.6M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-1,033.33%
Earnings growth (this year)+122.32%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-80.45%
P/E ratioNM
Price/Sales49.26
Price/Book4.65

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...-0.03-1.69%
TGTXTG Therapeutics Inc0.000.00%
TLGTTeligent Inc-0.08-1.02%
ADXSAdvaxis Inc-0.18-1.64%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)$0.55
Annual revenue (last year)$8.7M
Annual profit (last year)-$39.1M
Net profit margin-450.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Head-
Operations
Meryl J. Longval
Corporate headquarters
Tarrytown, New York

Forecasts